Epstein Barr Virus (EBV) Specific Cytotoxic T-Cells, Relapsed Lymphoma, ANGEL

Clinical trial NCT00058617 · COMPLETED

Trial details

NCT number: NCT00058617
Sponsor: Baylor College of Medicine
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Epstein-Barr Virus-Related Hodgkin Lymphoma Epstein-Barr Virus-Related Non-Hodgkin Lymphoma EBV Positive Plasma Cell Neoplasm

Start date: 1996-01-01
Primary completion: 2011-08-01
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.